It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1995.
1995 | Hyderabad, Telangana, India | Struck OffVera Pharma Limited, a struck off public limited company, was established on 08 June 1995 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1995PLC020644. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹8.50 Cr and a paid-up capital of ₹8.36 Cr.
It upholds a compliant status. Its leadership includes Venkateswara Rao Ghattamaneni (Additional Director), Maganti Bijili Kumari (Director), Gorrepati Ranga N B (Director). Past directors included Prasada Rao Venkata Viswa Jarjapu, Venkateswara Rao Yalla, Chandrashekar Gorrepati Rao. It holds no open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 3-6-69, Flat No. 409, Venkatarama Towers, Basheerbagh, Hyderabad, Telangana, 500029.
U24230TG1995PLC020644
020644
08 June 1995
₹8.50 Cr
₹8.36 Cr
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Vera Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkateswara Rao Ghattamaneni | Additional Director | 29 Jan 2024 | Current |
| Maganti Bijili Kumari | Director | 08 May 2014 | Current |
| Gorrepati Ranga N B | Director | 03 Sep 1997 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 06 Jun 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 02 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2014 | Past |
| Pramod Abcsdd | Director | 24 Jul 2014 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vera Pharma Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 99.99% decrease. The company also saw a substantial fall in profitability, with a 12576.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Vera Pharma had a promoter holding of 34.64% and a public holding of 65.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Nov 2012 | Bank Of India | ₹3.00 M | Satisfied |
| 02 May 2011 | Idbi Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vera Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vera Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vera Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Venkateswara Rao Ghattamaneni was appointed as a Additional Director was appointed as a Additional Director on 29 Jan 2024 & has been associated with this company since 1 year 10 months . was completed.
Vera Pharma Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
The activity Vera Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was completed.
A charge registered on 22 Nov 2012 via Charge ID 10389991 with Bank Of India was fully satisfied on 04 Feb 2016. was recorded as a recent event.
Progress on Maganti Bijili Kumari was appointed as a Director was appointed as a Director on 08 May 2014 & has been associated with this company since 11 years 6 months . was documented.
Progress on A charge with Bank Of India amounted to Rs. 0.30 Cr with Charge ID 10389991 was registered on 22 Nov 2012. was documented.
The CIN of Vera Pharma Limited is U24230TG1995PLC020644.
Vera Pharma Limited is headquartered at 3-6-69, Flat No. 409, Venkatarama Towers, Basheerbagh, Hyderabad, Telangana, 500029.
Vera Pharma Limited was incorporated on 08 June 1995.
The current directors of Vera Pharma Limited are
The primary industry of Vera Pharma Limited is Manufacturing.
Vera Pharma Limited is unlisted.
The authorized capital of Vera Pharma Limited is ₹8.50 Cr, and the paid-up capital is ₹8.36 Cr.
The compliance status of Vera Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX